Literature DB >> 6628702

Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor.

R S Farr, M L Wardlow, C P Cox, K E Meng, D E Greene.   

Abstract

Platelet-activating factor (PAF) is a phospholipid that activates platelets, induces inflammation, and causes profound alteration in the cardiopulmonary system. PAF from rabbit basophils and hog leukocytes is 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC). Human and other mammalian serums contain an acid-labile factor (ALF) that rapidly inactivates AGEPC. ALF is associated with low-density lipoproteins but can be dissociated from the lipoproteins with detergent followed by ultracentrifugation. Delipidated ALF has an isoelectric point of approximately 7.1, its molecular weight is unknown, and it will not react with goat anti-whole human serum, antialbumin, anti-alpha- or anti-beta-lipoproteins, or antiapolipoproteins A or B. ALF has the following characteristics: 1) is acid labile; 2) is Ca2+ independent; 3) has a pH optimum of 6.2; 4) can hydrolyze a four-carbon but not a six-carbon or longer chain fatty acid at the sn-2 position; 5) is independent of an ester or ether linkage at the sn-1 position; 6) is incapable of hydrolyzing sn-2-acetylphosphatidylethanolamine, which indicates the need for at least one methyl group on the choline moiety of AGEPC; 7) requires between 5 and 16 carbons at the sn-1 position to remove a three- or four-carbon fatty acid on the sn-2 position; 8) is inactivated by heating to 65 C for 30 min; 9) is pronase and trypsin sensitive but papain resistant; and 10) is a hydrophobic molecule and thus behaves like a membrane-associated enzyme. Thus, ALF is a specific phosphatide 2-acylhydrolase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628702

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  20 in total

1.  Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis.

Authors:  Y Yang; E M Nemoto; S A K Harvey; V M Subbotin; C R Gandhi
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

2.  Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis.

Authors:  Yong-Ping Yang; Xue-Mei Ma; Chun-Ping Wang; Jun Han; Yin-Ying Lu; Yi Xiang; Shu-Hui Su; Yong-Yi Feng
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

3.  Characterization of a platelet-activating factor acetylhydrolase secreted by the nematode parasite Nippostrongylus brasiliensis.

Authors:  M E Grigg; K Gounaris; M E Selkirk
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 4.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

Review 5.  The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis.

Authors:  M S Caplan; T Jilling
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

6.  Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking.

Authors:  T Imaizumi
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration.

Authors:  P H Pritchard
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

8.  Allergy-important advances in clinical medicine: platelet-activating factor.

Authors:  R S Farr
Journal:  West J Med       Date:  1984-10

9.  Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.

Authors:  R Korth; J Bidault; R Palmantier; J Benveniste; E Ninio
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

10.  Inactivation of platelet-activating factor by a putative acetylhydrolase from the gastrointestinal nematode parasite Nippostrongylus brasiliensis.

Authors:  C C Blackburn; M E Selkirk
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.